Core Scientific Financial Ratios
NASDAQ: CORZFinanceFinance: Consumer ServicesUSD
15.41+0.05 (+0.33%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Core Scientific ratio analysis
Core Scientific earned a net margin of -90.5% in FY 2025, up from -281.6% a year earlier. Gross margin was 11.9% compared with a median of 23.7% over the prior 5 years. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Core Scientific financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Price / sales | 15.94 | 7.70 | — | — | — | — |
| Gross margin | 11.9% | 23.7% | 24.6% | 1.3% | 43.9% | 15.6% |
| Operating margin | -77.0% | -27.8% | 1.8% | -329.5% | 24.2% | -10.5% |
| Net margin | -90.5% | -281.6% | -49.1% | -335.2% | 8.7% | -20.2% |
| Free cash flow margin | -141.3% | -10.2% | 9.7% | -27.9% | -10.4% | -39.4% |
| Return on equity (ROE) | — | — | — | — | 3.5% | -13.7% |
| Return on assets (ROA) | -12.3% | -97.4% | -34.6% | -265.7% | 1.9% | -81,373.3% |
| Debt / equity | — | — | — | — | 0.49 | — |
| Current ratio | 1.15 | 6.72 | 0.20 | 0.46 | 2.36 | — |
| Revenue growth | -37.5% | 1.6% | -21.5% | 17.6% | 802.7% | — |
| EPS growth | — | — | — | -3,250.0% | — | — |